Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa.

The majority of patients reported improvements in disease state, quality of life, and overall satisfaction after administration of high-dose ILTAC (20-40 mg/ml). These findings support the use of high-dose ILTAC for acute lesions of HS.